Autonomix Medical, Inc. AMIX

Q1 FY2027 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 13, 2026

Autonomix Medical, Inc. (AMIX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q1 of fiscal 2027, the quarter ended Jun 30, 2026, it reported revenue of $0 and a net loss of $2.7 million.

Revenue
$0
Net income
$-2.73M
+18.2% vs year-ago quarter
Operating cash flow
$-3.54M
-36.1% vs year-ago quarter
Free cash flow
$-2.90M
+65.0% vs year-ago quarter
EPS
—
Dividend per share
None
Shares outstanding
971,043
-81.1% vs year-ago quarter
Net cash
$10.69M
Q3 FY2025
Operating margin
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AMIX (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
The Woodlands, TX
SEC filer status
, Emerging growth company
SEC CIK
1617867

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2027
Jun 30, 2026
Q4 FY2026
Mar 31, 2026
Q3 FY2026
Dec 31, 2025
Q2 FY2026
Sep 30, 2025
Q1 FY2026
Jun 30, 2025
Revenue
$0
$0
$0
$0
$0
Operating income
-$2.8M
-$2.7M
-$3.3M
-$7.5M
-$3.4M
Net income
-$2.7M
-$2.7M
-$3.3M
-$7.5M
-$3.3M
Operating cash flow
-$3.5M
-$2.9M
-$3.0M
-$3.8M
-$2.6M
Free cash flow
—
-$2.9M
-$3.0M
-$3.8M
-$2.6M
Total assets
$4.0M
$7.6M
$10.2M
$7.9M
$9.0M
Total liabilities
$818,000
$1.7M
$1.6M
$1.5M
$2.0M
Stockholders' equity
$3.2M
$5.9M
$8.6M
$6.4M
$7.0M
Cash and investments
$3.5M
$7.0M
$9.9M
$7.5M
$8.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Shareholder vote results
Nov 3, 2026 Oct 29, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 14, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 26, 2026 Aug 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 28, 2026 Jul 28, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 15, 2026 Jul 13, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.